Document Type

Project

Publication Date

Spring 2018

Keywords

CSR, Corporate social responsibility, Japan, Japanese, Pharmaceutical

Abstract

As national medical expenditures increase in Japan, due to the country’s aging society, the Japanese pharmaceutical industry is under pressure to act as a good corporate citizen. This analysis examines factors related to Corporate Social Responsibility (CSR) in Japanese pharmaceutical companies. Following an exploration of the literature on CSR, a theoretical model is presented, where larger pharmaceutical companies with more owners and international stakeholders are more likely to engage in CSR activities. This model is tested in the context of CSR reporting, and results support the notion that more owners and international stakeholders are both positively related to CSR reporting in Japanese pharmaceutical companies.

Type

Text

Rights

Copying of this document in whole or in part is allowable only for scholarly purposes. It is understood, however, that any copying or publication of this document for commercial purposes, or for financial gain, shall not be allowed without the author’s written permission.

Language

English

Format

application/pdf

Share

COinS